Apendice II a: 1-1219

ISSN: 1139-8736
Depósito Legal: B-37271-2002
Copyright: © Silvia Montero Martínez

N	Word	Freq.
1	OF	21.545
2	THE	15.144
3	AND	10.801
4	IN	9.387
5	WITH	8.057
6	BE	7.067
7	A	6.530
8	TO	5.880
9	FOR	5.732
10	PATIENTS	4.889
11	CANCER	4.833
12	AL	4.444
13	ET	4.410
14	OR	4.358
15	THERAPY	3.386
16	TREATMENT	3.360
17	CLINICAL	3.137
18	JOURNAL	3.080
19	ONCOLOGY	2.988
20	RADIATION	2.837
21	CHEMOTHERAPY	2.608
22	STAGE	2.443
23	ARE	2.365
24	DISEASE	2.260
25	TUMORS	2.140
26	CELL	2.099
27	TUMOR	2.055
28	HAVE	1.749
29	BY	1.743
30	ON	1.660
31	SURVIVAL	1.601
32	AS	1.594
33	THAT	1.552
34	MAY	1.466
35	CARCINOMA	1.416
36	SURGERY	1.360
37	STUDY	1.357
38	THIS	1.350
39	FROM	1.289
40	THAN	1.161
41	GROUP	1.139
42	NOT	1.133
43	AN	1.094
44	HAS	1.087
45	AT	1.039
46	PRIMARY	1.039
47	SHOULD	1.014
48	LEUKEMIA	1.001
49	BEEN	980
50	INFORMATION	973
51	TRIAL	962
52	CHILDREN	949
53	TRIALS	916
54	RESULTS	915
55	MORE	896
56	HIGH	888
57	LYMPHOMA	867
58	SURGICAL	838
59	M	825
60	RANDOMIZED	824
61	I	816
62	ADVANCED	815
63	AFTER	795
64	THESE	786
65	DOSE	777
66	RISK	774
67	WHO	774
68	CAN	764
69	II	745
70	III	740
71	EVIDENCE	734
72	LYMPH	733
73	BONE	732
74	NO	725
75	B	707
76	CISPLATIN	680
77	REFERENCES	672
78	TREATED	670
79	HODGKIN'S	667
80	RESECTION	666
81	CHILDHOOD	662
82	MARROW	661
83	OTHER	658
84	NODES	647
85	SMALL	643
86	PDQ	642
87	PEDIATRIC	640
88	ALL	639
89	T	632
90	STANDARD	626
91	BUT	621
92	WAS	621
93	NEW	617
94	IF	609
95	MALIGNANT	604
96	YEARS	597
97	ALONE	589
98	ADJUVANT	580
99	AMERICAN	580
100	IRRADIATION	580
101	PHASE	571
102	PROGNOSIS	571
103	MOST	563
104	EVALUATION	559
105	USED	559
106	J	557
107	FOLLOWING	556
108	ACUTE	552
109	MEDICINE	552
110	RECURRENT	546
111	METASTATIC	538
112	S	538
113	USE	538
114	PROGNOSTIC	534
115	VERSUS	531
116	COMBINATION	529
117	RESPONSE	529
118	G	526
119	WITHOUT	522
120	LONG	514
121	TERM	509
122	CONSIDERED	505
123	METASTASES	502
124	NON	497
125	DIAGNOSIS	493
126	NODE	493
127	FACTORS	491
128	STAGING	487
129	BLOOD	485
130	C	485
131	WHEN	484
132	ASSOCIATED	481
133	LOCAL	480
134	BRAIN	468
135	E	467
136	INTERNATIONAL	467
137	R	461
138	ANALYSIS	460
139	MANAGEMENT	460
140	STUDIES	459
141	OPTIONS	455
142	LUNG	450
143	YEAR	450
144	LOW	447
145	NECK	447
146	GERM	437
147	SYSTEM	435
148	THERE	435
149	TRANSPLANTATIO+	432
150	HEALTH	431
151	LESS	431
152	P	431
153	SOME	427
154	GRADE	423
155	METASTASIS	420
156	RATE	420
157	D	417
158	CLASSIFICATION	414
159	ANY	413
160	ALSO	411
161	NATIONAL	411
162	THOSE	410
163	FLUOROURACIL	409
164	INVOLVEMENT	407
165	UNDER	407
166	RADIOTHERAPY	406
167	LESIONS	403
168	COMBINED	395
169	IT	394
170	FREE	393
171	LEVEL	392
172	BASED	391
173	BREAST	390
174	TISSUE	389
175	PATIENT	387
176	RECURRENCE	381
177	PLUS	379
178	SARCOMA	379
179	BIOLOGY	376
180	AGE	371
181	HEAD	371
182	CASES	369
183	IV	368
184	SUCH	366
185	RELAPSE	363
186	MEDICAL	361
187	REPORT	361
188	OUTCOME	358
189	DOXORUBICIN	357
190	HOWEVER	356
191	REGIONAL	355
192	WHICH	355
193	OVARIAN	352
194	PHYSICS	352
195	ENGLAND	349
196	FOLLOWED	344
197	LARGE	340
198	POSTOPERATIVE	340
199	PROSTATE	338
200	OCCUR	337
201	EXPERIENCE	334
202	WERE	333
203	COLORECTAL	332
204	COMPLETE	332
205	ONLY	332
206	ANNALS	330
207	OVERALL	328
208	DISTANT	325
209	RADICAL	324
210	RATES	322
211	UP	322
212	USUALLY	320
213	N	319
214	CHRONIC	313
215	REPORTED	310
216	SECOND	310
217	OVERVIEW	309
218	INCLUDE	308
219	SQUAMOUS	306
220	INITIAL	305
221	LOCALIZED	304
222	REMISSION	303
223	COMPARED	302
224	SUMMARY	292
225	EARLY	291
226	ONE	290
227	POSITIVE	290
228	ETOPOSIDE	289
229	MODIFIED	288
230	SINGLE	287
231	CONTROL	284
232	INSTITUTE	284
233	BOTH	282
234	ROLE	282
235	GYNECOLOGIC	281
236	BLADDER	279
237	BECAUSE	277
238	WILL	275
239	CANCERS	273
240	PELVIC	273
241	SOFT	273
242	ED	271
243	CM	270
244	ALTHOUGH	267
245	POOR	267
246	SITE	267
247	FOLLOW	266
248	OFTEN	266
249	FU	265
250	LIVER	265
251	EFFECTS	264
252	H	263
253	REGIMENS	261
254	GENERAL	260
255	TIME	259
256	MONTHS	258
257	LAST	257
258	UROLOGY	256
259	WOMEN	256
260	REGIMEN	254
261	ADULT	253
262	LYMPHOBLASTIC	253
263	PROSPECTIVE	252
264	SYNDROME	249
265	VINCRISTINE	249
266	BEAM	247
267	CYCLOPHOSPHAMI+	246
268	FIRST	242
269	EITHER	241
270	INTERFERON	241
271	APPROXIMATELY	240
272	JA	239
273	L	237
274	GIVEN	234
275	SITES	234
276	BENEFIT	231
277	INVASION	230
278	RESIDUAL	230
279	LIMITED	229
280	CELLS	228
281	INCIDENCE	228
282	THYROID	228
283	CARE	227
284	WELL	226
285	THERAPEUTIC	225
286	INTO	223
287	INCLUDING	222
288	RELATED	222
289	OPTION	220
290	IMPROVED	219
291	PP	219
292	SHOWN	219
293	SIGNIFICANT	219
294	ABOUT	218
295	RHABDOMYOSARCO+	218
296	COMMON	216
297	HAD	216
298	EXTERNAL	215
299	SARCOMAS	215
300	GREATER	213
301	APPROPRIATE	211
302	PRESENT	211
303	INCREASED	210
304	POSSIBLE	210
305	AGGRESSIVE	209
306	MELANOMA	209
307	EFFECTIVE	208
308	SIMILAR	205
309	LYMPHOMAS	204
310	INDUCTION	202
311	CERVICAL	201
312	GENERALLY	200
313	MANY	200
314	AGENTS	199
315	AVAILABLE	199
316	MULTIPLE	198
317	SKIN	198
318	PRIOR	197
319	INVASIVE	196
320	PHILADELPHIA	196
321	TYPE	195
322	DURING	194
323	FOUND	194
324	K	194
325	USING	194
326	COMPARISON	193
327	BIOPSY	192
328	AUTOLOGOUS	191
329	CENTRAL	190
330	EXCISION	190
331	PREOPERATIVE	190
332	REVIEW	189
333	ADENOCARCINOMA	188
334	APPROACH	188
335	TOTAL	187
336	BRITISH	186
337	METHOTREXATE	186
338	PRINCIPLES	185
339	F	184
340	PROFESSIONALS	184
341	QUESTIONS	184
342	YOU	184
343	CURE	183
344	JM	183
345	LEVELS	183
346	UNRESECTABLE	182
347	WILMS	182
348	CELLULAR	180
349	PER	180
350	INFUSION	178
351	SEMINARS	178
352	HISTOLOGIC	177
353	JR	177
354	PA	177
355	SYMPTOMS	177
356	IFOSFAMIDE	175
357	AML	174
358	COLON	174
359	FOUNDATION	174
360	NET	174
361	SELECTED	174
362	TOXIC	174
363	DIFFERENTIATED	173
364	LYMPHOCYTIC	173
365	RJ	173
366	SIZE	171
367	GLAND	170
368	RENAL	170
369	STAGES	170
370	ADULTS	169
371	CENTER	169
372	MYELOID	169
373	SUPPL	168
374	CANCERNET	167
375	CURRENT	167
376	LEUCOVORIN	167
377	MA	166
378	REFER	166
379	SECTION	166
380	TWO	166
381	BLEOMYCIN	165
382	SYSTEMIC	165
383	BETWEEN	164
384	NERVOUS	164
385	HEPATIC	163
386	IMPORTANT	163
387	INTERGROUP	163
388	LOCALLY	163
389	MODALITY	163
390	BETTER	162
391	INTENSIVE	159
392	PERFORMED	159
393	EUROPEAN	158
394	RECTAL	158
395	SPECIFIC	158
396	CARCINOMAS	156
397	IMPROVE	156
398	DIAGNOSED	155
399	EXTENT	155
400	DE	154
401	FAVORABLE	154
402	NODAL	154
403	REFRACTORY	154
404	CNS	153
405	COOPERATIVE	153
406	YOUNG	153
407	ALFA	152
408	FAILURE	152
409	INVOLVED	152
410	RESEARCH	152
411	PRESENCE	151
412	SERIES	151
413	THEY	151
414	HISTOLOGY	149
415	STEM	149
416	TESTICULAR	149
417	RESECTED	148
418	CLINICALLY	147
419	DISSECTION	147
420	HIGHER	147
421	GREATEST	146
422	SINCE	146
423	DEMONSTRATED	145
424	DOSES	144
425	ESPECIALLY	143
426	MJ	143
427	RECEIVED	143
428	ADDITION	141
429	COMPARING	141
430	CURATIVE	141
431	MAJORITY	141
432	NEGATIVE	141
433	EFFECT	140
434	MAJOR	140
435	MEDIAN	140
436	THEIR	140
437	DIFFUSE	139
438	GROW	139
439	CANNOT	138
440	DRUG	138
441	RETROSPECTIVE	138
442	SOCIETY	138
443	TAMOXIFEN	138
444	BILATERAL	137
445	EDS	137
446	MARGINS	137
447	OUT	137
448	OVER	137
449	ALLOGENEIC	136
450	INTERNAL	136
451	PREDNISONE	136
452	WHILE	136
453	AIDS	135
454	DATA	135
455	SPREAD	135
456	CHEST	134
457	VINBLASTINE	134
458	EFFICACY	133
459	ORAL	133
460	NUMBER	132
461	MYELOMA	131
462	PALLIATION	131
463	PREVIOUSLY	131
464	TRACT	131
465	ABVD	130
466	FIELD	130
467	INDICATED	130
468	LIPPINCOTT	130
469	NORMAL	130
470	RECEIVE	130
471	ADOLESCENTS	129
472	DIMENSION	129
473	RESPONSES	129
474	DO	128
475	NEOADJUVANT	128
476	POTENTIAL	128
477	SERUM	128
478	VERY	128
479	PULMONARY	127
480	UNIVERSITY	127
481	NEUROBLASTOMA	126
482	STATUS	126
483	SURVEY	126
484	FURTHER	125
485	LOWER	125
486	MYELOGENOUS	125
487	PERIPHERAL	125
488	GROUPS	124
489	LATE	124
490	TREATMENTS	124
491	ACTIVE	123
492	EXTENSION	123
493	META	123
494	W	123
495	WITHIN	123
496	YOUNGER	123
497	DEFINED	122
498	AJCC	121
499	CANDIDATES	121
500	CENTERS	121
501	OPTIMAL	121
502	PATHOLOGIC	121
503	RAVEN	121
504	EVALUATING	120
505	REQUIRE	120
506	ACTIVITY	119
507	ANAL	119
508	BASIS	119
509	CARBOPLATIN	119
510	DR	119
511	EXTENSIVE	119
512	FEATURES	119
513	LESION	119
514	MEDIASTINAL	119
515	MUST	119
516	SIGNIFICANCE	119
517	CONTAINING	118
518	DEVELOPMENT	118
519	UNTREATED	118
520	VIA	118
521	EPITHELIAL	117
522	PROCEEDINGS	117
523	SALVAGE	117
524	APPROACHES	116
525	ASSESSED	116
526	BEFORE	116
527	FREQUENTLY	116
528	GENE	116
529	MM	116
530	WE	116
531	ABDOMINAL	115
532	DL	115
533	PROSTATECTOMY	115
534	REQUIRED	115
535	SUPERFICIAL	115
536	DOES	114
537	ITS	114
538	PART	114
539	STRATEGY	114
540	TNM	114
541	COMMITTEE	113
542	CYTARABINE	113
543	EWING'S	113
544	FACTOR	113
545	FUNCTION	113
546	PALLIATIVE	113
547	SHOWED	113
548	WEEKS	113
549	CA	112
550	NEOPLASMS	112
551	CENTIMETERS	111
552	COMPLICATIONS	111
553	NEUROSURGERY	111
554	PROGRESSION	111
555	ANAPLASTIC	110
556	HEMATOLOGY	110
557	OSTEOSARCOMA	110
558	PRELIMINARY	110
559	PROTOCOL	110
560	RESULT	110
561	CONTROLLED	109
562	DM	109
563	DURATION	109
564	PACLITAXEL	109
565	SA	109
566	THEM	109
567	ADVANTAGE	108
568	CHROMOSOME	108
569	CONFINED	108
570	GASTROINTESTIN+	108
571	JP	108
572	MIXED	108
573	RARE	108
574	VAN	108
575	VS	108
576	WHETHER	108
577	WHOSE	108
578	CAVITY	107
579	DATE	107
580	VON	107
581	EVEN	106
582	GLIOMAS	106
583	HISTORY	106
584	MORTALITY	106
585	PJ	106
586	PROCEDURE	106
587	RARELY	106
588	SALIVARY	106
589	CAREFUL	105
590	CURABLE	105
591	DOCUMENT	105
592	INCLUDED	105
593	CONCURRENT	104
594	GOOD	104
595	HEPATOCELLULAR	104
596	MEDULLOBLASTOM+	104
597	RECOMMENDED	104
598	SEVERAL	104
599	ASTROCYTOMA	103
600	EXAMINATION	103
601	MEN	103
602	RESECTABLE	103
603	SEEN	103
604	UPPER	103
605	APPEAR	102
606	DRUGS	102
607	HORMONE	102
608	MOPP	102
609	MORBIDITY	102
610	TYPES	102
611	CONTINUOUS	101
612	IM	101
613	SINUS	101
614	COMBINATIONS	100
615	NECESSARY	100
616	PUBLISHERS	100
617	COMMONLY	99
618	COURSE	99
619	HUMAN	99
620	MAINLY	99
621	OBSTETRICS	99
622	PRACTICE	99
623	RA	99
624	V	99
625	ACHIEVED	98
626	ASSOCIATION	98
627	CHILDREN'S	98
628	FOLLICULAR	98
629	GASTRIC	98
630	MAINTENANCE	98
631	NEED	98
632	PATHOLOGY	98
633	APPEARS	97
634	CUTANEOUS	97
635	INGUINAL	97
636	LINE	97
637	PLEASE	97
638	IMPACT	96
639	NHL	96
640	PHEOCHROMOCYTO+	96
641	RE	96
642	THEREFORE	96
643	THROUGH	96
644	VALUE	96
645	BOWEL	95
646	CHOICE	95
647	IMAGING	95
648	JOINT	95
649	OLDER	95
650	OUR	95
651	ADMINISTRATION	94
652	AGENT	94
653	JE	94
654	MASS	94
655	TOPIC	94
656	US	94
657	CALL	93
658	DOCTOR	93
659	ENDOMETRIAL	93
660	ADDITIONAL	92
661	ASK	92
662	BONN	92
663	CANCERMAIL	92
664	CERVIX	92
665	CONNECTION	92
666	DOCTORS	92
667	FILL	92
668	GET	92
669	HELP	92
670	INTENDED	92
671	MADE	92
672	PEDIATRICS	92
673	REDISTRIBUTED	92
674	SECURE	92
675	SELECTION	92
676	SERVICE	92
677	USER	92
678	YOUR	92
679	BULKY	91
680	CONTENTS	91
681	INVADES	91
682	JD	91
683	MALIGNANCIES	91
684	PH	91
685	RETINOBLASTOMA	91
686	TRANSITIONAL	91
687	ARM	90
688	CT	90
689	DEFINITIVE	90
690	GENEVA	90
691	KAPOSI'S	90
692	PAGE	90
693	PROLONGED	90
694	SHOW	90
695	UNKNOWN	90
696	ADMINISTERED	89
697	GYNECOLOGY	89
698	INTERSTITIAL	89
699	ML	89
700	REQUIRES	89
701	SITU	89
702	THREE	89
703	BACK	88
704	CARCINOID	88
705	CGY	88
706	DETERMINATIONS	88
707	INCREASE	88
708	LANCET	88
709	MS	88
710	PREGNANCY	88
711	SUPERIOR	88
712	EVERY	87
713	FORMAL	87
714	HONCODE	87
715	HSP	87
716	LANDESREGIERUN+	87
717	MAIL	87
718	MESZ	87
719	NRW	87
720	ONGOING	87
721	PANCREATIC	87
722	PRESERVATION	87
723	PROGRESSIVE	87
724	QUADE	87
725	RAHMEN	87
726	SPONSORS	87
727	SUBSCRIBE	87
728	WALL	87
729	WEDNESDAY	87
730	CYSTECTOMY	86
731	INFECTION	86
732	JJ	86
733	LINKED	86
734	TECHNIQUES	86
735	AMONG	85
736	DIAGNOSTIC	85
737	INCLUDES	85
738	MASSES	85
739	OBSERVED	85
740	SCREENING	85
741	SUGGEST	85
742	PAPILLARY	84
743	TISSUES	84
744	TRANSPLANT	84
745	ACID	83
746	IMPROVEMENT	83
747	TREATING	83
748	UTERINE	83
749	ACHIEVE	82
750	ARCHIVES	82
751	BEING	82
752	DG	82
753	DISSEMINATED	82
754	LIFE	82
755	ORIGIN	82
756	PARTIAL	82
757	PARTICULARLY	82
758	REPORTS	82
759	SPECIALISTS	82
760	Y	82
761	AREAS	81
762	BEYOND	81
763	COURSES	81
764	DEVELOP	81
765	DIFFERENT	81
766	DISEASES	81
767	DUE	81
768	HEPATOBLASTOMA	81
769	INDIVIDUAL	81
770	JL	81
771	NEUROECTODERMA+	81
772	REMAINS	81
773	THERAPIES	81
774	THIRD	81
775	URINARY	81
776	BELOW	80
777	BODY	80
778	CONVENTIONAL	80
779	DEPENDS	80
780	DESIGNATIONS	80
781	EVALUATED	80
782	HIGHLY	80
783	JH	80
784	JW	80
785	RELAPSED	80
786	SHORT	80
787	SIGNIFICANTLY	80
788	SYMPTOMATIC	80
789	THORACIC	80
790	UNITED	80
791	CLEAR	79
792	DAILY	79
793	EPENDYMOMA	79
794	JC	79
795	KS	79
796	LAPAROTOMY	79
797	MELANOMAS	79
798	READER	79
799	REIMBURSEMENT	79
800	SUBSEQUENT	79
801	SURFACE	79
802	TEXT	79
803	BEST	78
804	BOARDS	78
805	CG	78
806	CITATIONS	78
807	EDITORIAL	78
808	IPSILATERAL	78
809	JUDGE	78
810	MULTIDISCIPLIN+	78
811	NASAL	78
812	NEWLY	78
813	POORLY	78
814	RANKING	78
815	STRENGTH	78
816	VOLUME	78
817	ABNORMALITIES	77
818	HORMONAL	77
819	JB	77
820	PELVIS	77
821	PROGRESS	77
822	REGION	77
823	RETROPERITONEA+	77
824	BENIGN	76
825	DETERMINE	76
826	EACH	76
827	PLATINUM	76
828	SAME	76
829	TOXICITY	76
830	DNA	75
831	HIV	75
832	POSTERIOR	75
833	AJ	74
834	ANTIGEN	74
835	DETERMINED	74
836	NERVE	74
837	PRESENTATION	74
838	REMOVAL	74
839	VULVAR	74
840	WILLIAMS	74
841	X	74
842	ABOVE	73
843	COMPLETELY	73
844	DID	73
845	DIFFERENCE	73
846	INDOLENT	73
847	INTERMEDIATE	73
848	PROCEDURES	73
849	ROSENBERG	73
850	SEPARATE	73
851	HYSTERECTOMY	72
852	KNOWN	72
853	MALIGNANCY	72
854	OBSERVATION	72
855	PROSTATIC	72
856	SECONDARY	72
857	AORTIC	71
858	COMPUTED	71
859	ELECTRON	71
860	JS	71
861	PRODUCE	71
862	RC	71
863	TIS	71
864	VAGINA	71
865	ADJACENT	70
866	CYTOGENETIC	70
867	DIFFERENTIATIO+	70
868	ESOPHAGEAL	70
869	FINDINGS	70
870	GUIDELINES	70
871	LYMPHADENECTOM+	70
872	OBTAINED	70
873	ORCHIECTOMY	70
874	PARA	70
875	PRIMITIVE	70
876	ANOTHER	69
877	BIOLOGIC	69
878	DAY	69
879	LEAST	69
880	ME	69
881	MYELODYSPLASTI+	69
882	NORTH	69
883	POPULATION	69
884	PROTEIN	69
885	RECEIVING	69
886	RECTUM	69
887	TECHNIQUE	69
888	AM	68
889	CURRENTLY	68
890	KIDNEY	68
891	MINIMAL	68
892	NCI	68
893	POST	68
894	RB	68
895	SCAN	68
896	SD	68
897	UNILATERAL	68
898	CHARACTERISTIC+	67
899	CLASSIFIED	67
900	CURED	67
901	DONE	67
902	GLIOMA	67
903	IA	67
904	MD	67
905	NEPHRECTOMY	67
906	PANCREAS	67
907	PREVENTION	67
908	SEMINOMA	67
909	SOUTHWEST	67
910	USEFUL	67
911	VAGINAL	67
912	ALTERNATING	66
913	ELEVATED	66
914	EXPRESSION	66
915	EXTENDED	66
916	FAMILY	66
917	MESOTHELIOMA	66
918	MICROSCOPIC	66
919	MUCOSA	66
920	ORGAN	66
921	QUALITY	66
922	BRACHYTHERAPY	65
923	CASE	65
924	CHILDRENS	65
925	CONSOLIDATION	65
926	DACARBAZINE	65
927	GM	65
928	HAIRY	65
929	LOCATION	65
930	LOSS	65
931	MONOCLONAL	65
932	SUPPORTIVE	65
933	WORSE	65
934	AREA	64
935	COUNT	64
936	DECREASED	64
937	HALF	64
938	HM	64
939	INFANTS	64
940	INOPERABLE	64
941	MOLECULAR	64
942	REDUCTION	64
943	RESONANCE	64
944	RESPOND	64
945	VIRUS	64
946	ACCEPTED	63
947	DECREASE	63
948	EXCELLENT	63
949	MAGNETIC	63
950	MARKERS	63
951	MITOMYCIN	63
952	MODALITIES	63
953	O	63
954	STATES	63
955	ADRENAL	62
956	ALPHA	62
957	CCG	62
958	CEREBRAL	62
959	DEGREE	62
960	EA	62
961	OPHTHALMOLOGY	62
962	PINEAL	62
963	POG	62
964	WOULD	62
965	CHEMOTHERAPEUT+	61
966	FIVE	61
967	FORM	61
968	FREQUENCY	61
969	INTRAVENOUS	61
970	MF	61
971	OUTCOMES	61
972	OVARY	61
973	SYNDROMES	61
974	TROPHOBLASTIC	61
975	BN	60
976	CONSIDERATION	60
977	CRITERIA	60
978	DESCRIBED	60
979	DESIGNED	60
980	GROSS	60
981	GY	60
982	IB	60
983	IIA	60
984	INVESTIGATORS	60
985	MALE	60
986	MOERTEL	60
987	MULTICENTER	60
988	NIH	60
989	POTENTIALLY	60
990	PUBLISHED	60
991	THOMAS	60
992	VARIOUS	60
993	VULVA	60
994	WM	60
995	ACADEMY	59
996	BOLUS	59
997	CRANIAL	59
998	DEVITA	59
999	INTRACRANIAL	59
1000	IVA	59
1001	NEOPLASIA	59
1002	NOTED	59
1003	REDUCED	59
1004	RELATIVELY	59
1005	VT	59
1006	WIDE	59
1007	ACCORDING	58
1008	ASTROCYTOMAS	58
1009	BLESSING	58
1010	DEFINITIONS	58
1011	GP	58
1012	IIB	58
1013	ISOLATED	58
1014	LB	58
1015	LITERATURE	58
1016	RECURRENCES	58
1017	SS	58
1018	ABLATION	57
1019	ADEQUATE	57
1020	ASYMPTOMATIC	57
1021	DA	57
1022	DELAYED	57
1023	EASTERN	57
1024	INVOLVING	57
1025	JOHNSON	57
1026	LIKELY	57
1027	MANTLE	57
1028	PITUITARY	57
1029	PLANNING	57
1030	SM	57
1031	UNCOMMON	57
1032	VARIETY	57
1033	WHERE	57
1034	YORK	57
1035	ANTERIOR	56
1036	ARISE	56
1037	CONSIDERATIONS	56
1038	CONTRALATERAL	56
1039	DEATH	56
1040	DIAMETER	56
1041	EVALUATE	56
1042	IIIA	56
1043	LASER	56
1044	LYMPHOCYTE	56
1045	NASOPHARYNGEAL	56
1046	RESISTANT	56
1047	SUGGESTS	56
1048	URETHRAL	56
1049	UTERUS	56
1050	AMERICA	55
1051	ANDERSON	55
1052	EMBRYONAL	55
1053	EXTREMITY	55
1054	IDENTICAL	55
1055	IDENTIFIED	55
1056	IMMUNODEFICIEN+	55
1057	MG	55
1058	MUCH	55
1059	PERFORMANCE	55
1060	RM	55
1061	TESTING	55
1062	URETHRA	55
1063	ABSENCE	54
1064	ALTERNATIVE	54
1065	BURKITT'S	54
1066	CAREFULLY	54
1067	DH	54
1068	IMMEDIATE	54
1069	INVOLVES	54
1070	PARANASAL	54
1071	PLASMA	54
1072	PROPHYLACTIC	54
1073	RANDOMISED	54
1074	SOMETIMES	54
1075	TA	54
1076	THYMOMA	54
1077	UNTIL	54
1078	EQUIVALENT	53
1079	HAEMATOLOGY	53
1080	HELLMAN	53
1081	METER	53
1082	MYCOSIS	53
1083	NOW	53
1084	PC	53
1085	PLATELET	53
1086	RR	53
1087	RTOG	53
1088	THUS	53
1089	ADRENOCORTICAL	52
1090	CLINICOPATHOLO+	52
1091	CYCLES	52
1092	DIFFICULT	52
1093	FUNGOIDES	52
1094	GROIN	52
1095	HS	52
1096	PACKER	52
1097	PERITONEAL	52
1098	REMISSIONS	52
1099	RL	52
1100	SJ	52
1101	SMITH	52
1102	STILL	52
1103	TERATOMA	52
1104	U	52
1105	WHOLE	52
1106	WJ	52
1107	DACTINOMYCIN	51
1108	DS	51
1109	HISTOLOGICALLY	51
1110	INTERVAL	51
1111	LA	51
1112	LM	51
1113	LYMPHATIC	51
1114	LYMPHOID	51
1115	NONSEMINOMATOU+	51
1116	OCCASIONALLY	51
1117	PARATHYROID	51
1118	PRIMARILY	51
1119	SEVERE	51
1120	TEAM	51
1121	UNDIFFERENTIAT+	51
1122	ARTERIAL	50
1123	BLASTS	50
1124	CAUSE	50
1125	DETECTED	50
1126	DUCT	50
1127	FRENCH	50
1128	GESTATIONAL	50
1129	GOV	50
1130	HTTP	50
1131	HYPERFRACTIONA+	50
1132	JF	50
1133	LONGER	50
1134	MP	50
1135	RECEPTOR	50
1136	RT	50
1137	TX	50
1138	YET	50
1139	CJ	49
1140	CONFIRMED	49
1141	CSF	49
1142	DJ	49
1143	FUNCTIONAL	49
1144	IMPORTANCE	49
1145	LARGER	49
1146	MELPHALAN	49
1147	MILLIGRAMS	49
1148	NONE	49
1149	OUTSIDE	49
1150	PS	49
1151	RD	49
1152	SPARING	49
1153	SPECIAL	49
1154	SQUARE	49
1155	SURGICALLY	49
1156	BILE	48
1157	CLINICS	48
1158	CORD	48
1159	FORMS	48
1160	LH	48
1161	LOOK	48
1162	ORGANS	48
1163	PAIN	48
1164	PATTERN	48
1165	PREFERRED	48
1166	PROJECT	48
1167	PROVEN	48
1168	SCANS	48
1169	TOPICAL	48
1170	ANEMIA	47
1171	BENEFITS	47
1172	CR	47
1173	EL	47
1174	FREQUENT	47
1175	IMPLICATIONS	47
1176	METHODS	47
1177	MH	47
1178	MR	47
1179	OCCULT	47
1180	PSA	47
1181	RELATIVE	47
1182	RP	47
1183	SL	47
1184	SUPRATENTORIAL	47
1185	SURVEILLANCE	47
1186	CEREBELLAR	46
1187	CONSERVATIVE	46
1188	DEPENDING	46
1189	DEVELOPED	46
1190	ENDOCRINE	46
1191	ES	46
1192	FEWER	46
1193	FOSSA	46
1194	IMMATURE	46
1195	INFLUENCE	46
1196	INVESTIGATION	46
1197	JT	46
1198	LEUKAEMIA	46
1199	LEVAMISOLE	46
1200	MANUAL	46
1201	NASOPHARYNX	46
1202	NOTE	46
1203	NUCLEAR	46
1204	OBSTRUCTION	46
1205	RESERVED	46
1206	RS	46
1207	SETTING	46
1208	SOLID	46
1209	WEEK	46
1210	BUNDY	45
1211	CHOP	45
1212	DIFFERENCES	45
1213	GENETIC	45
1214	LIKE	45
1215	MUSCLE	45
1216	PATTERNS	45
1217	PROGRAM	45
1218	RESCUE	45
1219	SPINAL	45

Índice general I Índice Apéndice II I Siguiente